These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15079089)

  • 21. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin.
    Martchenko M; Jeong SY; Cohen SN
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15583-8. PubMed ID: 20713715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.
    Liu S; Crown D; Miller-Randolph S; Moayeri M; Wang H; Hu H; Morley T; Leppla SH
    Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12424-9. PubMed ID: 19617532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
    Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
    J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-range stabilization of anthrax protective antigen upon binding to CMG2.
    Mullangi V; Mamillapalli S; Anderson DJ; Bann JG; Miyagi M
    Biochemistry; 2014 Sep; 53(38):6084-91. PubMed ID: 25186975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis.
    Dowling O; Difeo A; Ramirez MC; Tukel T; Narla G; Bonafe L; Kayserili H; Yuksel-Apak M; Paller AS; Norton K; Teebi AS; Grum-Tokars V; Martin GS; Davis GE; Glucksman MJ; Martignetti JA
    Am J Hum Genet; 2003 Oct; 73(4):957-66. PubMed ID: 12973667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2.
    Verma A; Moayeri M; Mocca CP; O'Mard D; Ma Q; Leppla SH; Burns DL
    Vaccine; 2022 Jul; 40(32):4318-4321. PubMed ID: 35710508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the cellular receptor for anthrax toxin.
    Bradley KA; Mogridge J; Mourez M; Collier RJ; Young JA
    Nature; 2001 Nov; 414(6860):225-9. PubMed ID: 11700562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax.
    Wycoff KL; Belle A; Deppe D; Schaefer L; Maclean JM; Haase S; Trilling AK; Liu S; Leppla SH; Geren IN; Pawlik J; Peterson JW
    Antimicrob Agents Chemother; 2011 Jan; 55(1):132-9. PubMed ID: 20956592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring anthrax toxin receptor dissociation from the protective antigen by NMR.
    Rajapaksha M; Eichler JF; Hajduch J; Anderson DE; Kirk KL; Bann JG
    Protein Sci; 2009 Jan; 18(1):17-23. PubMed ID: 19177347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between anthrax toxin receptors and protective antigen.
    Scobie HM; Young JA
    Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor-specific requirements for anthrax toxin delivery into cells.
    Rainey GJ; Wigelsworth DJ; Ryan PL; Scobie HM; Collier RJ; Young JA
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13278-83. PubMed ID: 16141341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a receptor-based inhibitory penta-unit-conjugated peptide to enhance anthrax toxin neutralization.
    Lee SC; Yoon MY
    Int J Biol Macromol; 2020 Nov; 163():327-335. PubMed ID: 32619663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of recombinant anthrax toxin receptor (ATR/CMG2) fused with human Fc in planta.
    Andrianov V; Brodzik R; Spitsin S; Bandurska K; McManus H; Koprowski H; Golovkin M
    Protein Expr Purif; 2010 Apr; 70(2):158-62. PubMed ID: 19796689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody.
    Li G; Qu Y; Cai C; Kong Y; Liu S; Zhang J; Zhao J; Fu L; Xu J; Chen W
    Biochem Biophys Res Commun; 2009 Aug; 385(4):591-5. PubMed ID: 19486894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.
    Rogers MS; Cryan LM; Habeshian KA; Bazinet L; Caldwell TP; Ackroyd PC; Christensen KA
    PLoS One; 2012; 7(6):e39911. PubMed ID: 22768167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving the anti-toxin abilities of the CMG2-Fc fusion protein with the aid of computational design.
    Xi Y; Wu X; Gao L; Shao Y; Peng H; Chen H; Chen H; Hu X; Yue J
    PLoS One; 2014; 9(8):e104674. PubMed ID: 25101992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Domain 4 of the anthrax protective antigen maintains structure and binding to the host receptor CMG2 at low pH.
    Williams AS; Lovell S; Anbanandam A; El-Chami R; Bann JG
    Protein Sci; 2009 Nov; 18(11):2277-86. PubMed ID: 19722284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capillary morphogenesis gene 2 (CMG2) mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis.
    Cryan LM; Tsang TM; Stiles J; Bazinet L; Lee SL; Garrard S; Madrian E; Roberts C; Payne J; Jensen A; Frankel AE; Ackroyd PC; Christensen KA; Rogers MS
    Angiogenesis; 2022 Aug; 25(3):397-410. PubMed ID: 35212873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (19)F nuclear magnetic resonance and crystallographic studies of 5-fluorotryptophan-labeled anthrax protective antigen and effects of the receptor on stability.
    Chadegani F; Lovell S; Mullangi V; Miyagi M; Battaile KP; Bann JG
    Biochemistry; 2014 Feb; 53(4):690-701. PubMed ID: 24387629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient co-expression of post-transcriptional gene silencing suppressors for increased in planta expression of a recombinant anthrax receptor fusion protein.
    Arzola L; Chen J; Rattanaporn K; Maclean JM; McDonald KA
    Int J Mol Sci; 2011; 12(8):4975-90. PubMed ID: 21954339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.